Publications by authors named "C Dees"

Claim this Profile
L
Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation.
Xuezhi Hong, Yanhua Xiao, Haodong Qi, Shihao Zhu, Tim Filla, Clara Dees

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disturbed Spatial WNT Activation-A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis.
Sara Chenguiti Fakhouri, Honglin Zhu, Yi-Nan Li, Moritz Ronicke, Aleix Rius Rigau, Clara Dees

Arthritis Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD.
Xuezhi Hong, Yanhua Xiao, Liyan Xu, Lichong Shen, Ranjana Neelagar, Clara Dees

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Janina Auth, Fabian Müller, Simon Völkl, Nadine Bayerl, Jörg H W Distler, Clara Dees

Lancet Rheumatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers, Claire Dees

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis